5-Bromo-2-chloro-1,8-naphthyridine

Catalog No.: 
ACLIRM728
CAS No.: 
1260880-09-8
Molecular Formula: 
C8H4BrClN2
Molecular Weight: 
243.49
5-Bromo-2-chloro-1,8-naphthyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$534.00InquiryInquiry
250mg98%$713.00InquiryInquiry
1g98%$1783.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-Bromo-2-chloro-1,8-naphthyridine
IUPAC Name5-bromo-2-chloro-1,8-naphthyridine
MDL No.MFCD16659775
Molecular FormulaC8H4BrClN2
Molecular Weight243.49
SMILESClC1=NC2=NC=CC(Br)=C2C=C1
InChI KeyYBQFBLYNIIRDPC-UHFFFAOYSA-N
Synonym5-Bromo-2-chloro-1,8-naphthyridine;1,8-Naphthyridine, 5-bromo-2-chloro-
CAS No.1260880-09-8

Safety Data

Pictogram
Toxic
Signal Word
Danger
Hazard Statement(s)
H301-H311-H331
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P310-P330-P361-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACLIRM728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEDUL684 route compound structure diagram
    ACEDUL68415936-10-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIRM728 route product structure diagram
    ACLIRM7281260880-09-8
Inquiry

2. ACLIRM728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLTZU019 route compound structure diagram
    ACLTZU01984249-14-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIRM728 route product structure diagram
    ACLIRM7281260880-09-8
Inquiry

3. ACLIRM728 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYDHF860 route compound structure diagram
    ACYDHF86045644-21-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLIRM728 route product structure diagram
    ACLIRM7281260880-09-8
Inquiry

Comments (0)